Internal Medicine, Hematology & Oncology · Wichita, KS
NPI
1528263043
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
818 N Emporia St Ste 403
Wichita, KS, 67214
Phone (316) 262-4467
Groups this clinician bills Medicare through
Medicare paid, 2024
$9.1M
452,500 services
Medicare patients, 2024
1,821
Average age 75
Drug cost, 2024
$6.4M
2,697 prescriptions
Company payments, 2025
$3,124
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy Deutsch was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 44,460 times for 55 patients. In total Jeremy Deutsch billed 452,500 services in 238 codes, and Medicare paid $9.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-02.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 44,460 | 55 | $0.22 | $9,680 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 33,400 | 53 | $44.71 | $1.5M |
| J0185 Injection, aprepitant, 1 mg | Office | 25,610 | 82 | $1.35 | $35K |
| J9299 Injection, nivolumab, 1 mg | Office | 24,200 | 29 | $24.56 | $594K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 24,000 | 24 | $0.88 | $21K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 23,760 | 33 | $39.26 | $933K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 17,090 | 26 | $2.32 | $40K |
| J0897 Injection, denosumab, 1 mg | Office | 15,960 | 76 | $20.58 | $328K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 14,000 | 64 | $4.40 | $62K |
| J1930 Injection, lanreotide, 1 mg | Office | 11,640 | 23 | $38.43 | $447K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 10,560 | 33 | $21.41 | $226K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 9,974 | 18 | $0.05 | $539 |
| J9267 Injection, paclitaxel, 1 mg | Office | 8,598 | 22 | $0.08 | $689 |
| J9264 Injection, paclitaxel protein-bound particles, 1 mg | Office | 7,800 | 15 | $10.47 | $82K |
| A9575 Injection, gadoterate meglumine, 0.1 ml | Office | 6,740 | 41 | $0.09 | $639 |
By year: 2022 $6.5M for 302,222 services; 2023 $8.6M for 397,085 services; 2024 $9.1M for 452,500 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,428 | 659 | $8.63 | $21K |
| 85007 Blood Count | 2,392 | 653 | $3.69 | $8,834 |
| 85027 Blood Count | 2,390 | 653 | $6.30 | $15K |
| 80053 Clinical Chemistry | 2,312 | 631 | $10.28 | $24K |
| 88185 Surgical Pathology Examination | 529 | 21 | $16.78 | $8,877 |
| 83615 Clinical Chemistry | 405 | 156 | $5.92 | $2,398 |
| 84443 Clinical Chemistry | 191 | 52 | $16.46 | $3,144 |
| 82728 Clinical Chemistry | 186 | 93 | $13.36 | $2,485 |
| 82306 Clinical Chemistry | 182 | 146 | $28.87 | $5,254 |
| 83540 Clinical Chemistry | 178 | 92 | $6.34 | $1,129 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy Deutsch prescribed most often to Medicare patients was Anastrozole, with 767 prescriptions and refills. In total Jeremy Deutsch wrote 2,697 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 767 | 1,627 | 175 | $9,696 |
| Ondansetron Hcl Generic | 149 | 149 | 83 | $3,069 |
| Acyclovir Generic | 114 | 158 | 23 | $1,836 |
| Prednisone Generic | 106 | 118 | 31 | $450 |
| Lenalidomide Generic | 95 | 95 | 11 | $1.2M |
| Dexamethasone Generic | 84 | 100 | 35 | $1,972 |
| Letrozole Generic | 68 | 141 | 13 | $1,039 |
| Gabapentin Generic | 65 | 81 | 19 | $702 |
| Prochlorperazine Maleate Generic | 58 | 60 | 44 | $759 |
| Oxycodone Hcl Generic | 51 | 51 | 18 | $1,208 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 51 | 51 | 20 | $1,997 |
| Alendronate Sodium Generic | 50 | 118 | 15 | $294 |
| Levothyroxine Sodium Generic | 50 | 82 | Under 11 | $223 |
| Hydroxyurea Generic | 45 | 103 | 11 | $920 |
| Imbruvica Ibrutinib | 42 | 42 | Under 11 | $702K |
Brand drugs: 409 claims; generic drugs: 2,288 claims; opioid claims: 145.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy Deutsch $3,124 ($3,124 in general payments such as food, travel and fees) from 50 companies. The largest payer was Novartis Pharmaceuticals Corporation with $283.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 15 | $283 |
| Pfizer Inc. PFE | 17 | $270 |
| Abbvie Inc. ABBV | 14 | $236 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $220 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $197 |
| Janssen Biotech, Inc. JNJ | 5 | $155 |
| Celgene Corporation BMY | 4 | $89.4 |
| Gilead Sciences, Inc. GILD | 5 | $84.76 |
| Astellas Pharma US Inc 4503.T | 5 | $84.76 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $68.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.